Advanced glycation endproducts increase EPC apoptosis and decrease nitric oxide release via MAPK pathways

Biomedicine and Pharmacotherapy

Volumn 64, Issue 1, 2010, Pages 35-43

  Shen, C ^a   Li, Q ^a   Zhang, Y C ^b   Ma, G ^a   Feng, Y ^a   Zhu, Q ^a   Dai, Q ^a   Chen, Z ^a   Yao, Y ^a   Chen, L ^a   Jiang, Y ^a   Liu, N ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Advanced glycation endproducts; Apoptosis; Cyclooxygenase 2; Endothelial nitric oxide synthase; Endothelial progenitor cells; MAP kinase; Nitric oxide

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CASPASE 3; CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NITRIC OXIDE; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; FLOW CYTOMETRY; GLYCOSYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEM CELL; SUPERNATANT; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; NITRIC OXIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; STEM CELLS; TIME FACTORS;

EID: 73149109072     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2009.03.002     Document Type: Article

References (18)

1. Werner N., Kosiol S., Schiegl T., Ahlers P., Walenta K., Link A., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353 10 (2005) 999-1007
2. Yan S.D., Schmidt A.M., Anderson G.M., Zhang J., Brett J., Zou Y.S., et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269 13 (1994) 9889-9897
3. Negrean M., Stirban A., Stratmann B., Gawlowski T., Horstmann T., Gotting C., et al. Effects of low- and high-advanced glycation end product meals on macro- and microvascular endothelial function and oxidative stress in patients with type-2 diabetes mellitus. Am J Clin Nutr 85 5 (2007) 1236-1243
4. Scheubel R.J., Kahrstedt S., Weber H., Holtz J., Friedrich I., Borgermann J., et al. Depression of progenitor cell function by advanced glycation endproducts (AGEs): potential relevance for impaired angiogenesis in advanced age and diabetes. Exp Gerontol 41 5 (2006) 540-548
5. Sun C., Liang C., Ren Y., Zhen Y., He Z., Wang H., et al. Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways. Basic Res Cardiol (2008)
6. Kern T.S., Du Y., and Levin Bcl-2 L.A. Endothelial death, and capillary degeneration in diabetic retinopathy invest. Ophthalmol Vis Sci 48 (2007) 3638
7. Thum T., Fraccarollo D., Schultheiss M., Froese S., Galuppo P., Widder J.D., et al. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 56 3 (2007) 666-674
8. Asahara T., Murohara T., Sullivan A., Silver M., Van Der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 5302 (1997) 964-967
9. Kalka C., Masuda H., Takahashi T., Gordon R., Tepper O., Gravereaux E., et al. Vascular endothelial growth factor (165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 86 12 (2000) 1198-1202
10. Kalka C., Masuda H., Takahashi T., Kalka-Moll W.M., Silver M., Kearney M., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 97 7 (2000) 3422-3427
11. Tepper O.M.B.A., Galiano R.D.M.D., Capla J.M.B.A., Kalka C.M.D., Gagne P.J.M.D., Jacobowitz G.R.M.D., et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106 22 (2002) 2781-2786
12. Capla J.M., Grogan R.H., Callaghan M.J., Galiano R.D., Tepper O.M., Ceradini D.J., et al. Diabetes impairs endothelial progenitor cell-mediated blood vessel formation in response to hypoxia. Plast Reconstr Surg 119 1 (2007) 59-70
13. Balestrieri M.L., Rienzo M., Felice F., Rossiello R., Grimaldi V., Milone L., et al. High glucose downregulates endothelial progenitor cell number via SIRT1. Biochim Biophys Acta 1784 6 (2008) 936-945
14. Chen Y.H., Lin S.J., Lin F.Y., Wu T.C., Tsao C.R., Huang P.H., et al. High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes 56 6 (2007) 1559-1568
15. Zhang W., Wang R., Han S-f, Bu L., Wang S-w, Ma H., et al. [alpha]-Linolenic acid attenuates high glucose-induced apoptosis in cultured human umbilical vein endothelial cells via PI3K/Akt/eNOS pathway. Nutrition 23 10 (2007) 762-770
16. Ho F.M., Lin W.W., Chen B.C., Chao C.M., Yang C.-R., Lin L.Y., et al. High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-kappa B and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway. Cell Signal 18 3 (2006) 391-399
17. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
18. Stehouwer C.D., Gall M.A., Twisk J.W., Knudsen E., Emeis J.J., and Parving H.H. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type-2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 51 (2002) 1157-1165